FI65438C - Foerfarande foer framstaellning av farmakologiskt aktiva estrar av fosfonomyrsyra - Google Patents

Foerfarande foer framstaellning av farmakologiskt aktiva estrar av fosfonomyrsyra Download PDF

Info

Publication number
FI65438C
FI65438C FI783931A FI783931A FI65438C FI 65438 C FI65438 C FI 65438C FI 783931 A FI783931 A FI 783931A FI 783931 A FI783931 A FI 783931A FI 65438 C FI65438 C FI 65438C
Authority
FI
Finland
Prior art keywords
phenyl
group
vis
formula
acid
Prior art date
Application number
FI783931A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI783931A (fi
FI65438B (fi
Inventor
Aoke John Erik Helgstrand
Karl Nils-Gunnar Johansson
Alfons Misiorny
Jan-Olof Noren
Goeran Bertil Stening
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of FI783931A publication Critical patent/FI783931A/fi
Publication of FI65438B publication Critical patent/FI65438B/fi
Application granted granted Critical
Publication of FI65438C publication Critical patent/FI65438C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3886Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C07F9/3891Acids containing the structure -C(=X)-P(=X)(XH)2, (X = O, S, Se)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4062Esters of acids containing the structure -C(=X)-P(=X)(XR)2 or NC-P(=X)(XR)2, (X = O, S, Se)
    • C07F9/4065Esters of acids containing the structure -C(=X)-P(=X)(XR)2, (X = O, S, Se)
FI783931A 1977-12-22 1978-12-20 Foerfarande foer framstaellning av farmakologiskt aktiva estrar av fosfonomyrsyra FI65438C (fi)

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
GB5358277 1977-12-22
GB5358377 1977-12-22
GB5358377 1977-12-22
GB5358277 1977-12-22
GB5358077 1977-12-22
GB5358077 1977-12-22
GB5358177 1977-12-22
GB5358177 1977-12-22
GB7828553 1978-07-03
GB7828555 1978-07-03
GB7828553 1978-07-03
GB7828552 1978-07-03
GB7828552 1978-07-03
GB7828548 1978-07-03
GB7828555 1978-07-03
GB7828548 1978-07-03

Publications (3)

Publication Number Publication Date
FI783931A FI783931A (fi) 1979-06-23
FI65438B FI65438B (fi) 1984-01-31
FI65438C true FI65438C (fi) 1984-05-10

Family

ID=27571200

Family Applications (2)

Application Number Title Priority Date Filing Date
FI783931A FI65438C (fi) 1977-12-22 1978-12-20 Foerfarande foer framstaellning av farmakologiskt aktiva estrar av fosfonomyrsyra
FI783932A FI68626C (fi) 1977-12-22 1978-12-20 Foerfarande foer framstaellning av nya terapeutiskt aktiva hydroxikarbonylfosfonsyraderivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI783932A FI68626C (fi) 1977-12-22 1978-12-20 Foerfarande foer framstaellning av nya terapeutiskt aktiva hydroxikarbonylfosfonsyraderivat

Country Status (14)

Country Link
US (4) US4372894A (fr)
EP (2) EP0003007B1 (fr)
JP (2) JPS54109951A (fr)
AT (1) AT369017B (fr)
AU (1) AU530031B2 (fr)
CA (2) CA1144937A (fr)
DE (2) DE2861729D1 (fr)
DK (2) DK148631C (fr)
FI (2) FI65438C (fr)
HK (1) HK33584A (fr)
IE (1) IE48011B1 (fr)
MY (1) MY8500058A (fr)
NO (2) NO156611C (fr)
SG (1) SG82383G (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1144937A (fr) * 1977-12-22 1983-04-19 Dke J.E. Helgstrand Derives aromatiques, composes pharmaceutiques et methode pour combattre les infections a virus
GB8501374D0 (en) * 1985-01-18 1985-02-20 Wellcome Found Treatment of aids
US4806532A (en) * 1985-10-08 1989-02-21 Mayo Foundation For Medical Education And Research Inhibition of epithelial phosphate transport
US6492352B1 (en) * 1985-10-31 2002-12-10 Astra Lakemedel Aktiebolag Method for the control and treatment of acquired immunodeficiency syndrome (AIDS)
US5025003A (en) * 1989-09-18 1991-06-18 E. R. Squibb & Sons, Inc. Isoprenoid phosphinylformic acid squalene synthetase inhibitors
US5166386A (en) * 1989-09-18 1992-11-24 E. R. Squibb & Sons, Inc. Process of making isoprenoid phosphinylformic acid squalene synthetase inhibitors
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US5132414A (en) * 1990-05-10 1992-07-21 Dana-Farber Cancer Institute, Inc. Dideoxynucleoside-5'-phosphonoformic acid compounds
US5696277A (en) * 1994-11-15 1997-12-09 Karl Y. Hostetler Antiviral prodrugs
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
US6096730A (en) * 1997-07-24 2000-08-01 University Of Kentucky Research Foundation Phosphonated agents and their antiangiogenic and antitumorigenic use
US5869469A (en) * 1997-08-18 1999-02-09 Queen's University At Kingston Phosphonocarboxylate compounds for treating amyloidosis
CA2300910C (fr) * 1997-08-18 2008-02-26 Queen's University At Kingston Composes de phosphono-carboxylate concus pour le traitement de l'amylose
NZ568553A (en) * 1998-02-11 2010-02-26 Bellus Health Int Ltd Treatment of inflammation, AB-induced cell toxicity, neuronal cell death or neuronal loss in subjects suffering from AlzheimerÆs disease
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
US6329356B1 (en) 1998-04-10 2001-12-11 Neurochem, Inc. Phosphono-carboxylate compounds for treating amyloidosis
US6310073B1 (en) * 1998-07-28 2001-10-30 Queen's University At Kingston Methods and compositions to treat glycosaminoglycan-associated molecular interactions
JP4726304B2 (ja) * 1999-04-28 2011-07-20 ベルス ヘルス (インターナショナル) リミティッド アミロイドーシスを治療するための組成物および方法
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
KR20080003945A (ko) * 1999-12-23 2008-01-08 뉴로겜 인터내셔널 리미티드 대뇌 아밀로이드 혈관병증을 조절하는 화합물 및 방법
ES2268394T3 (es) * 2002-04-01 2007-03-16 Pfizer Inc. Inhibidores de piranona y pirandiona de la arn polimerasa dependiente del arn del virus de la hepatitis c.
DOP2003000641A (es) * 2002-05-10 2003-11-15 Pfizer Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan
US7148226B2 (en) * 2003-02-21 2006-12-12 Agouron Pharmaceuticals, Inc. Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
US20040214178A1 (en) * 2003-04-24 2004-10-28 Agouron Pharmaceuticals, Inc. Reporter-selectable Hepatitis C virus replicon
US7414076B2 (en) 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
SI1781662T1 (sl) * 2004-08-18 2011-07-29 Pfizer Zaviralci RNA-odvisne RNA-polimeraze hepatitisa C in sestavki in zdravljenja, v katerih se uporabljajo
ITMI20041822A1 (it) * 2004-09-24 2004-12-24 Pharmaproducts Uk Ltd "agente terapeutico utile per il trattamento di neoplasie plasmacellulari"
CN101103018A (zh) * 2004-11-16 2008-01-09 神经化学(国际)有限公司 治疗cns和淀粉样蛋白-相关疾病的化合物
CA2900876A1 (fr) 2004-12-22 2006-08-17 Bhi Limited Partnership Methodes et compositions de traitement de maladies liees a l'amyloide
BRPI0620637A2 (pt) * 2005-12-22 2011-11-16 Neurochem Int Ltd uso de compostos na preparação de medicamentos para a prevenção ou o tratamento de nefropatia diabética, complicação de desordem renal e dislipidemia, redução dos nìveis de lipìdeos e ácido úrico no soro, e aumento do clearance de creatinina e da função renal
DK2089417T3 (en) 2006-10-12 2015-03-23 Bhi Ltd Partnership Methods, Compounds, Compositions and Vehicles for Delivery of 3-Amion-1-Propanesulfonic Acid
MX2009006768A (es) * 2006-12-22 2009-08-31 Bellus Health Int Ltd Metodos, compuestos, y composiciones para tratar trastornos metabolicos y diabetes.
US20080293648A1 (en) * 2007-01-05 2008-11-27 Saha Pharmaceuticals, Inc. Compositions and Methods for Cancer Treatment
DE102012103717A1 (de) * 2012-04-27 2013-11-14 Westfälische Wilhelms-Universität Münster Arzneimittel zur Behandlung von Tumorerkrankungen
CN105830271B (zh) * 2013-12-19 2018-11-16 宇部兴产株式会社 非水电解液、使用了其的蓄电装置及其中使用的膦酰基甲酸化合物
ES2578902B1 (es) * 2014-12-29 2017-07-07 Agencia Pública Empresarial Sanitaria Costa Del Sol Uso de análogos del ión pirofosfato para el tratamiento de la infección por VPH
CN109400645A (zh) * 2017-08-18 2019-03-01 四川海思科制药有限公司 一种磷酸衍生物及制备方法和用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155597A (en) * 1961-06-23 1964-11-03 Monsanto Co Extractive separation process
CH513590A (de) 1968-05-24 1971-10-15 Du Pont Carbamoylphosphonat enthaltender Pflanzenwachstumsregler
US3997544A (en) * 1968-05-24 1976-12-14 E. I. Du Pont De Nemours And Company Plant growth regulant carbamoylphosphonates
US3846512A (en) * 1968-05-24 1974-11-05 Du Pont Carbamoylphosphonates
US3533995A (en) * 1968-08-27 1970-10-13 Fmc Corp Heat stabilization of polyester resin with alkyl dialkoxyphosphinyl formate
GB1317768A (en) 1969-08-14 1973-05-23 Du Pont Plant growth regulants
US3849102A (en) * 1969-08-14 1974-11-19 Du Pont Plant growth regulant method
US3767795A (en) * 1971-02-25 1973-10-23 Abbott Lab Method for combating certain virus infection
HU171255B (hu) 1973-07-23 1977-12-28 Du Pont Kompozicii dlja regulirovki rosta rastenijj
US3943201A (en) * 1973-07-23 1976-03-09 E. I. Du Pont De Nemours And Comapny Alkoxy carboxycarbonylphosphonic acid esters
US4017297A (en) * 1975-08-29 1977-04-12 E. I. Du Pont De Nemours And Company Phosphonates for the control of bindweed
US4092412A (en) * 1976-04-30 1978-05-30 Abbott Laboratories Treatment of herpes simplex infections
CA1069526A (fr) * 1976-04-30 1980-01-08 Thomas R. Herrin Esters de phosphore de l'acide phosphonoacetique
US4052439A (en) * 1976-04-30 1977-10-04 Abbott Laboratories Carboxylic esters of phosphonoacetic acid
SE7607496L (sv) * 1976-07-01 1978-01-02 Astra Laekemedel Ab Sett for bekempning av virusinfektioner
CA1144937A (fr) * 1977-12-22 1983-04-19 Dke J.E. Helgstrand Derives aromatiques, composes pharmaceutiques et methode pour combattre les infections a virus

Also Published As

Publication number Publication date
SG82383G (en) 1985-03-08
DK148632B (da) 1985-08-19
EP0003007A2 (fr) 1979-07-11
NO156611B (no) 1987-07-13
JPS54109951A (en) 1979-08-29
NO784331L (no) 1979-06-25
EP0003275B1 (fr) 1981-09-02
DE2861045D1 (en) 1981-11-26
MY8500058A (en) 1985-12-31
EP0003007A3 (en) 1979-08-08
FI783931A (fi) 1979-06-23
FI783932A (fi) 1979-06-23
JPS6254118B2 (fr) 1987-11-13
FI65438B (fi) 1984-01-31
JPS6330885B2 (fr) 1988-06-21
AU4268278A (en) 1979-06-28
NO784330L (no) 1979-06-25
US4591583A (en) 1986-05-27
DK148631B (da) 1985-08-19
EP0003275A1 (fr) 1979-08-08
FI68626B (fi) 1985-06-28
AT369017B (de) 1982-11-25
US4386081A (en) 1983-05-31
US4372894A (en) 1983-02-08
US4536400A (en) 1985-08-20
DK148631C (da) 1986-03-03
CA1140049A (fr) 1983-01-25
DE2861729D1 (en) 1982-05-19
JPS54106431A (en) 1979-08-21
IE48011B1 (en) 1984-09-05
DK148632C (da) 1986-03-03
EP0003007B1 (fr) 1982-04-07
AU530031B2 (en) 1983-06-30
NO154751C (no) 1986-12-17
ATA921778A (de) 1982-04-15
IE782493L (en) 1979-06-22
FI68626C (fi) 1985-10-10
DK564278A (da) 1979-06-23
NO154751B (no) 1986-09-08
DK564178A (da) 1979-06-23
NO156611C (no) 1987-10-21
CA1144937A (fr) 1983-04-19
HK33584A (en) 1984-04-27

Similar Documents

Publication Publication Date Title
FI65438C (fi) Foerfarande foer framstaellning av farmakologiskt aktiva estrar av fosfonomyrsyra
US6812224B2 (en) Phosphorous organic compounds and their use
Herrin et al. Synthesis and anti-herpes simplex activity of analogs of phosphonoacetic acid
Aaron et al. The Stereochemistry of Asymmetric Phosphorus Compounds. IV. The Synthesis and Stereochemistry of Displacement Reactions of Optically Active Isopropyl Methylphosphonochloridate
US6753324B2 (en) Phosphorous organic compounds and their use
Martin et al. The determination of polar substituent constants for the dialkoxy-and diarylphosphono and trialkyl-and triarylphosphonium groups
Vinopal et al. Selective toxicity of phoxim (phenylglyoxylonitrile oxime O, O-diethyl phosphorothioate)
Tolkmith Organic Polyphosphorus Compounds. I. Synthesis of Aliphatic Amido Polyphosphates
CA1108176A (fr) Obtention d'arylalkyl et d'aryloxyalkylphosphonates
US3016326A (en) New organic phosphorus compounds
EP0003008A1 (fr) Dérivés de carbamoylphosphonates, préparations pharmaceutiques et leur utilisation contre les virus
Lee et al. In vitro inhibition of acetylcholinesterase by O, O-dimethyl S-aryl phosphorothioates
IE47694B1 (en) Aromatic derivatives of phosphonoformic acid,processes for their preparation,pharmaceutical compositions containing them and their use for combating virus infections
CA1156651A (fr) Derives de l'acide hydroxycarbonylphosphonique
KR840002463B1 (ko) 방향족 포스포노 포름산 모노에스테르의 제조방법
SU694043A1 (ru) Фосфоросодержашие симм-триазины,обладающиеиНСЕКТОАКАРицидНОй АКТиВНОСТью
US2594455A (en) Process of making a dialkyl phosphoryl monoethyl hydrocarbon phosphonate
AT369016B (de) Verfahren zur herstellung neuer hydroxycarbonyl- phosphonsaeurederivate sowie von deren physiologisch akzeptablen salzen und optischen antipoden
Nishizawa Studies on the Organophosphorus Insecticides: Part II. Synthesis and Toxicity of Phosphoroates and Phosphorothioates Containing Phenylacrylate or Phenylacrylonitrile Radicals Part III. Synthesis and Toxicity of Phosphoroate and Phosphorothioates Containing Carboethoxy-cycloalkenyl Groups
Murdock Synthesis, chemical and biological properties of a series of O, O-diethyl S-aryl phosphorothiolates
MXPA01000488A (en) Phosphorous organic compounds and their use

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: ASTRA LAEKEMEDEL AKTIEBOLAG